LiVeritas Biosciences, Inc.

LiVeritas Biosciences, Inc. is revolutionizing testing for drug quality, safety, and efficacy, turning it 100x faster without sacrificing accuracy & precision. We are addressing the biopharma industry's need for a streamlined solution to efficiently identify drug candidates with the highest chance of FDA approval. Our solution is called Mass Spec-as-a-Service (MSaaS), which offers a streamlined LC-MS workflow from start to finish in less than 3 weeks.